"Super-Refractory Status Epilepticus in Children: A Retrospective Cohort Study"
by Alejandra Vasquez et al. 
Pediatr Crit Care Med. 2021 Jun 14.  doi: 10.1097/PCC.0000000000002786.

Conclusions: Super-refractory status epilepticus patients had delayed initiation of nonbenzodiazepine antiseizure medication treatment, higher number of medical complications and mortality, and lower return to neurologic baseline than nonsuper-refractory status epilepticus patients, although these associations were not adjusted for potential confounders. Treatment approaches following the first continuous infusion were heterogeneous, reflecting limited information to guide clinical decision-making in super-refractory status epilepticus..

CLICK TO VISIT PUBMED

Comments
* The email will not be published on the website.